Scott D Klemens, OD
Optometry · Forest Grove
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Pacific University · 30 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Klemens’s office at (503) 352-2756 to ask if they take your plan before you enroll.
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Cataract surgery | 1-10 | None |
Year by year
| 2023 | 16 | 36 | 71 | 0.98 | $4,245 | $1,892 |
| 2022 | 20 | 40 | 71 | 0.81 | $4,738 | $1,949 |
| 2021 | 13 | 23 | 70 | 0.99 | $2,934 | $1,408 |
| 2020 | 33 | 50 | 70 | 1.22 | $6,022 | $2,964 |
| 2019 | 59 | 122 | 68 | 1.23 | $14,509 | $5,234 |
| 2018 | 21 | 34 | 67 | 1.18 | $3,629 | $1,982 |
| 2017 | 52 | 69 | 72 | 0.91 | $16,514 | $3,446 |
| 2016 | 40 | 49 | 72 | 0.93 | $13,703 | $3,125 |
| 2015 | 40 | 64 | 70 | 0.96 | $10,451 | $2,928 |
| 2014 | 44 | 70 | 73 | 1.29 | $7,025 | $2,867 |
| 2013 | 18 | 30 | 72 | 0.89 | $4,172 | $1,785 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Return visit (30+ min) | 11 | $685 | $62 |
2020: 1 service
| Return visit (30+ min) | 22 | $1,705 | $78 |
2019: 5 services
| Return visit (30+ min) | 31 | $1,511 | $49 |
| New patient visit (45+ min) | 12 | $895 | $75 |
| Short return visit (20+ min) | 16 | $789 | $46 |
| Exam of visual field with extended testing | 14 | $690 | $38 |
| Imaging of optic nerve | 17 | $472 | $25 |
2017: 2 services
| Established patient complete exam of visual system | 31 | $1,938 | $63 |
| New patient complete exam of visual system | 19 | $896 | $47 |
2016: 2 services
| Established patient complete exam of visual system | 20 | $1,201 | $60 |
| New patient complete exam of visual system | 13 | $1,108 | $85 |
2015: 3 services
| New patient complete exam of visual system | 16 | $869 | $54 |
| Short return visit (20+ min) | 11 | $733 | $43 |
| Established patient complete exam of visual system | 12 | $680 | $52 |
2014: 2 services
| Established patient complete exam of visual system | 18 | $806 | $45 |
| New patient complete exam of visual system | 13 | $693 | $53 |
Medicaid work
$790 in 2024
Medicaid paid $790 for 13 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 13 | $790 |
| 2024 | 13 | 1 | 13 | $790 |
| 2022 | 24 | 2 | 12 | $504 |
| 2021 | 63 | 4 | 19 | $1,298 |
| 2020 | 131 | 3 | 17 | $2,512 |
| 2019 | 619 | 6 | 25 | $14,551 |
| 2018 | 108 | 3 | 16 | $2,719 |
See the largest Medicaid services in earlier years
2022
| Lens, polycarbonate or equal, any index, per lens | 12 | $360 |
| Frames, purchases | 12 | $144 |
2021
| Lens, polycarbonate or equal, any index, per lens | 15 | $450 |
| Fitting of monofocal spectacles | 17 | $425 |
| Frames, purchases | 19 | $228 |
| Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 12 | $195 |
2020
| Fitting of monofocal spectacles | 47 | $1,174 |
| Frames, purchases | 64 | $768 |
| Lens, polycarbonate or equal, any index, per lens | 20 | $570 |
2019
| Lens, polycarbonate or equal, any index, per lens | 162 | $4,834 |
| Fitting of monofocal spectacles | 185 | $4,548 |
| Frames, purchases | 212 | $2,571 |
| Return visit (30+ min) | 15 | $1,204 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 13 | $887 |
| Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 32 | $507 |
2018
| Fitting of monofocal spectacles | 56 | $1,375 |
| Lens, polycarbonate or equal, any index, per lens | 40 | $1,200 |
| Frames, purchases | 12 | $144 |
Drugs they prescribed that Part D paid
$14,847
Pharmacies billed $14,847 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 74) in 2024. At or below the middle of the specialty; the typical optometry clinician is at 0%.
51 generic and 23 brand-name prescriptions · $14,847 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cyclosporine | 13 | $5,020 | $386 |
| Latanoprost | 27 | $407 | $15 |
| Dorzolamide | 11 | $249 | $23 |
| Azelastine | 12 | $141 | $12 |
Year by year
| 2024 | 74 | None | 0% (0) | 31% | $14,847 |
| 2023 | 72 | 15 | 0% (0) | 40% | $13,576 |
| 2022 | 75 | 16 | 0% (0) | 37% | $8,879 |
| 2021 | 79 | 19 | 0% (0) | 44% | $8,134 |
| 2020 | 81 | 17 | 0% (0) | 51% | $16,928 |
| 2019 | 106 | 26 | 0% (0) | 56% | $16,170 |
| 2018 | 135 | 55 | 0% (0) | 43% | $13,692 |
| 2017 | 478 | 155 | 0% (0) | 21% | $47,730 |
| 2016 | 639 | 185 | 0% (0) | 20% | $45,167 |
| 2015 | 689 | 175 | 0% (0) | 31% | $34,627 |
| 2014 | 610 | 168 | 0% (0) | 61% | $28,696 |
| 2013 | 676 | 178 | 0% (0) | 59% | $26,652 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Cyclosporine | 11 | $4,178 | $380 |
| Latanoprost | 32 | $650 | $20 |
2022: 2 drugs
| Brimonidine | 13 | $1,594 | $123 |
| Latanoprost | 34 | $687 | $20 |
2021: 2 drugs
| Brimonidine | 18 | $1,939 | $108 |
| Latanoprost | 43 | $923 | $21 |
2020: 2 drugs
| Azopt | 12 | $7,163 | $597 |
| Latanoprost | 34 | $518 | $15 |
2019: 3 drugs
| Azopt | 13 | $5,161 | $397 |
| Brimonidine | 16 | $1,121 | $70 |
| Latanoprost | 48 | $796 | $17 |
2018: 5 drugs
| Bimatoprost | 15 | $2,491 | $166 |
| Latanoprost | 49 | $886 | $18 |
| Dorzolamide-Timolol | 21 | $525 | $25 |
| Brimonidine | 12 | $461 | $38 |
| Timolol Maleate | 14 | $150 | $11 |
2017: 7 drugs
| Restasis | 36 | $18,537 | $515 |
| Bimatoprost | 75 | $14,201 | $189 |
| Travatan Z | 11 | $4,548 | $413 |
| Latanoprost | 160 | $3,614 | $23 |
| Dorzolamide-Timolol | 61 | $1,465 | $24 |
| Timolol Maleate | 54 | $475 | $9 |
| Brimonidine | 33 | $218 | $7 |
2016: 10 drugs
| Restasis | 37 | $15,922 | $430 |
| Bimatoprost | 88 | $7,484 | $85 |
| Travatan Z | 12 | $3,909 | $326 |
| Latanoprost | 228 | $3,596 | $16 |
| Dorzolamide-Timolol | 83 | $2,882 | $35 |
| Timolol Maleate | 77 | $529 | $7 |
| Brimonidine | 31 | $464 | $15 |
| Fluorometholone | 11 | $463 | $42 |
| Prednisolone Acetate | 12 | $309 | $26 |
| Dorzolamide | 16 | $271 | $17 |
2015: 10 drugs
| Restasis | 29 | $8,809 | $304 |
| Latanoprost | 331 | $7,113 | $21 |
| Travatan Z | 14 | $3,421 | $244 |
| Dorzolamide-Timolol | 85 | $3,064 | $36 |
| Bimatoprost | 19 | $972 | $51 |
| Brimonidine | 52 | $885 | $17 |
| Timolol Maleate | 68 | $811 | $12 |
| Fluorometholone | 13 | $426 | $33 |
| Dorzolamide | 21 | $274 | $13 |
| Neomycin-Polymyxin-Dexameth | 14 | $116 | $8 |
2014: 8 drugs
| Latanoprost | 303 | $9,096 | $30 |
| Restasis | 19 | $4,243 | $223 |
| Pataday | 14 | $3,153 | $225 |
| Dorzolamide-Timolol | 63 | $1,900 | $30 |
| Timolol Maleate | 81 | $1,049 | $13 |
| Brimonidine | 40 | $537 | $13 |
| Neomycin-Polymyxin-Dexameth | 15 | $178 | $12 |
| Dorzolamide | 12 | $129 | $11 |
2013: 6 drugs
| Latanoprost | 333 | $9,526 | $29 |
| Restasis | 16 | $4,333 | $271 |
| Pataday | 18 | $2,748 | $153 |
| Dorzolamide-Timolol | 76 | $2,159 | $28 |
| Timolol Maleate | 110 | $1,941 | $18 |
| Brimonidine | 63 | $558 | $9 |
Money from drug and device companies
$26 in 2025
| 2025 | 1 | 1 | None | $26 |
| 2024 | 2 | 2 | None | $39 |
| 2023 | 1 | 1 | None | $20 |
| 2022 | 1 | 1 | None | $42 |
| 2021 | 1 | 1 | None | $17 |
| 2020 | 2 | 2 | None | $39 |
| 2019 | 1 | 1 | None | $24 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Mallinckrodt Hospital Products | Acthar | $26 | 1 payment
|
See the published payment
| Mallinckrodt Hospital Products | Meals · 2025-11-19 | Acthar | $26 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $39
| Tarsus Pharmaceuticals | None | $22 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $17 | 1 payment
|
2023: $20
| Horizon Therapeutics plc | Tepezza | $20 | 1 payment
|
2022: $42
| Horizon Therapeutics plc | Tepezza | $42 | 1 payment
|
2021: $17
| Allergan | None | $17 | 1 payment
|
2020: $39
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $20 | 1 payment
|
| Carl Zeiss Meditec AG | None Specified | $19 | 1 payment
|
2019: $24
| Johnson & Johnson Vision Care | Acuvue | $24 | 1 payment
|
Professional record
- NPI
- 1184854739
- Licence
- AZ 1739, CA 33856TLG, OR 3320AT
- Trained
- Southern California College of Optometry, 2009
- Group
- Pacific University
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 2043 College Way, Forest Grove, OR, 97116
- NPI first listed
- 2009-07-16
- NPI last updated
- 2019-07-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3021 Meridian Ave, San Jose, CA, 95124